Female Sexual Dysfunction and female sexual arousal disorder resources on diagnosis and treatment options for endocrinologists and physicians

Keeping you up to date with the latest clinical trial information

Female Sexual Dysfunction

New Approach to Declining Androgens and Sexual Apathy in Ageing Women
Sexual thoughts and fantasies are a joy of life. Sexual desire is fun and a vital part of good health. It is a much appreciated basis for relationships between women and their partners.

Hypertension in Postmenopausal Women
The incidence of cardiovascular and cerebrovascular diseases in women is low before the menopause but after the age of 50 years they become the leading cause of mortality and morbidity for women living in most developed countries.

Current Issues and New Developments in the Endocrine Care of Climacteric Women
Within just one century the average lifespan of women in Western countries has significantly increased and nowadays about a third of a woman’s life is lived after the menopause.

Female Sexual Dysfunction: Prevalence Among Italian Healthy Women

Purposes of this study are:

To determine the prevalence of female sexual dysfunctions among Italian general population
To determine which sexual domains are more frequently compromised
To evaluate which of the factors we took into consideration are more frequently associated with FSD

Related Articles

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness

Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches

Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy

The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women

Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial

A 24-Week Fixed Dose Trial of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meet standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.

Related Articles

Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain

Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects

In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain

Effects of Spinal Cord Injury on Female Sexual Response
The long term aims of this project are to 1) Understand the effect of varying degrees and levels of SCI and dysfunction (SCI/D) on females sexual response: 2) Identify the specific neuronal pathways involved in female sexual responses; and 3) Develop and evaluate new assessment and treatment methods for neurogenic sexual dysfunction in women.

Related Articles

Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity

The impact of spinal cord injury on sexual function: concerns of the general population

Physiologic parameters associated with sexual arousal in women with incomplete spinal cord injuries

A multicenter study of women's self-reported reproductive health after spinal cord injury

Sexual rehabilitation of women with a spinal cord injury

Articles :	a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies :	a b c d e f g h i j k l m n o p q r s t u v w x y z
Events :	a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords :	a b c d e f g h i j k l m n o p q r s t u v w x y z
Specialities :	Acromegaly Diabetes Diabetic Complications Erectile Dysfunction Female Sexual Dysfunction Growth Hormone Deficiency Hypogonadism Menopause & Hormone Replacement Therapy Thyroid disorders
Other Touch Group sites:	Cardiology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease